Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis
Listen to this summary
The authors aimed to determine whether disease-modifying therapies (DMTs) for multiple sclerosis (MS) influence the risk of developing non-infectious uveitis (NIU). Their study found that certain DMT classes, particularly nucleic acid synthesis inhibitors/S1P modulators and fumarates, are associated with a reduced incidence of NIU compared to glatiramer acetate, suggesting potential for personalized MS treatment and repurposing these therapies for NIU in other populations.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from American journal of ophthalmology
View all →May 8, 2026 · American journal of ophthalmology
Have Deprivation Amblyopia Outcomes Improved for Infants with Unilateral Cataracts?
May 8, 2026 · American journal of ophthalmology
Genotype-phenotype correlations in RPGRIP1-associated retinal dystrophy in a nationwide Japanese cohort
May 7, 2026 · American journal of ophthalmology
Tubercular Retinitis: Clinical Spectrum and Multimodal Imaging Features of an Insufficiently Characterized Entity
May 5, 2026 · American journal of ophthalmology
Imaging Biomarkers for Early Differentiation of Candida and Aspergillus Endogenous Fungal Endophthalmitis: Multicenter Optical Coherence Tomography-Based Analysis
May 4, 2026 · American journal of ophthalmology
Unsuccessful Clinical Trials in Retina: Lessons Learned
May 4, 2026 · American journal of ophthalmology
AUTO MACHINE LEARNING FOR DIABETIC RETINOPATHY SCREENING: A HEAD-TO-HEAD MULTI-PLATFORM COMPARISON AGAINST HUMAN GRADERS AND IDX-DR
More in Ophthalmology
View all →May 10, 2026 · Lancet (London, England)
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 9, 2026 · Lancet (London, England)
The role of community-based blood pressure screening in improving hypertension care
May 8, 2026 · Lancet (London, England)
Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial
May 6, 2026 · The New England journal of medicine
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
